Navigation Links
FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
Date:3/8/2010

About Fenwal

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components.  Fenwal is unique in the depth of its experience and commitment to transfusion medicine.  The company offers the broadest range of products for the automated and manual collection of blood and blood components.  Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories.  Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components.  Today, the company's products and advanced collection and separation technologies are used to help treat patients on six continents.  Fenwal, Inc. is based in Lake Zurich, Illinois.  For more information, please visit www.fenwalinc.com.

(1) FDA, 2009.  "FDA Approves First Additive Solution for Platelet Storage Up to 5 Days," United States Food and Drug Administration Press Release. [accessed: '/>"/>

SOURCE Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
2. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
3. FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
4. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
5. FDA Clears a Test for Ovarian Cancer
6. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
7. U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States
8. FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets
9. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
10. William Cork Joins Fenwal as Chief Technology Officer
11. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... 2015  AbbVie (NYSE: ABBV ) ... its neuroscience and oncology development programs have been ... American Academy of Neurology annual meeting in ... The accepted abstracts feature results from studies evaluating ... treatments in AbbVie,s pipeline. Presentations will include Phase ...
(Date:2/26/2015)...  Mail-service and specialty pharmacies will save ... health plans $23.3 billion over the next decade, ... Management Association (PCMA). "Home delivery of ... easiest ways to reduce health costs," said PCMA ... should resist efforts to restrict these cost-saving tools." ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... PROMUS(TM) Element(TM) Platinum Chromium StentNATICK, Mass., Feb. 3 ... announced the beginning of patient enrollment in the PLATINUM ... PROMUS(TM) Element(TM) Everolimus-Eluting Coronary Stent. The first U.S. ... of the Rockies in Loveland, Colorado by Thomas Downes, ...
... Adolescents and young adults who are heavy users ... have disrupted brain development, according to a new ... the brain that interconnect brain regions involved in ... The findings are of particular concern because adolescence ...
Cached Medicine Technology:Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 2Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 3Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 4Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 5Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults 2Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults 3
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 The ... training and learning materials to potential EMTs and firefighters, ... for Bitcoins as a way to raise charitable donations ... ends in Medellin, Columbia, will be held on March ... the run will begin at 3:30 p.m. , ...
(Date:2/27/2015)... Calif. (PRWEB) February 27, 2015 Hispanics ... liver-disease death, between four and 12 years earlier than ... from UC Davis Health System. , While previous research ... than other populations, the new study -- published online ... is believed to be the first to pinpoint racial ...
(Date:2/27/2015)... A new study published in the Journal of ... on a regular basis and prostate cancer. While cycling is ... more hours per week a man spends cycling, the more ... increased importance on prostate cancer screening methods. , “This study ... at patents’ risk factors for developing prostate cancer,” says Kia ...
(Date:2/27/2015)... 27, 2015 Today, February 27th, is "Shine ... , along with LXR Organics and Living ... Campaign to raise awareness and promote prevention, rescue and restoration ... by the END IT Coalition, slavery is the 2nd largest ... exists in 167 countries around the world. Slavery includes bonded ...
(Date:2/27/2015)... Altec Products, Inc., announced today that Bartlett, ... their doc-link for Dynamics Partner of the Year. BPW ... for their customers in all different industries with a ... BPW have worked side-by-side to successfully help clients implement ... “We are so impressed by the success that BPW ...
Breaking Medicine News(10 mins):Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 3
... Obesity Rates Rise - Webinar to Crack the Code, ... insights from a,comprehensive study of over 1,000 U.S. adults ... as diet and exercise guidelines. In,"Wellness in America: Lifestyles ... to achieve personal health and wellness goals is,explored and ...
... evidence that noncoding RNAs and interactions between noncoding genes ... was previously understood. The research, published by Cell Press ... may be useful for identifying tumor-specific signatures associated with ... exhibit genetic alterations in oncogenes or tumor suppressor genes. ...
... Nearly 30 years after Nobel laureate Linus Pauling famously and ... team of Johns Hopkins scientists have shown that in mice ... can indeed inhibit the growth of some tumors just ... , The conventional wisdom of how antioxidants such as vitamin ...
... Sept. 10, 2007 Smoking, eating fattening foods and ... lead to poor health and cardiovascular disease more so ... Southwestern Medical Center have found that women dont change these ... with heart disease. , The scientists, reporting in the September ...
... See" Approach to Identifying,Learning Disabilities, SAN MATEO, ... of the Charles and Helen Schwab Foundation dedicated ... problems,announced today their launch of a new interactive ... a learning problem. This one-of-a-kind,resource, "When Your Child ...
... Sept. 10 Genomic,Health, Inc. (Nasdaq: GHDX ... the use of quantitative real-time polymerase chain reaction,(RT-PCR), ... measuring the hormone,receptors, estrogen receptor (ER) and progesterone ... study identified multiple genes,including the 21 genes in ...
Cached Medicine News:Health News:Why Are Most Health & Wellness Products Doomed to Failure? 2Health News:Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas 2Health News:How vitamin C stops the big 'C' 2Health News:Women less likely than men to change habits that increase heart disease risk 2Health News:Schwablearning.Org Launches Interactive Tool to Help Parents of Children Struggling in School 2Health News:Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium 2Health News:Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium 3Health News:Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium 4
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Substrate Plasma for Factor XII Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XII....
Enzyme Immunoassay of Factor IX Antigen by ELISA Method, 96 tests....
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Medicine Products: